Media invitation - Three innovative and highly promising breast cancer research projects

MONTREAL, May 31, 2019 /CNW Telbec/ - 

A research partnership between the Canadian Cancer Society (CCS) and the CQDM will fund researchers from here and build on cutting edge technologies such as:

1. The 3D printing of live tumours from the cancer cells of breast cancer patients
2. Artificial intelligence to predict response to chemotherapy in breast cancer patients as a means of preventing treatment-related toxicity
3. DNA repair as a means of developing drugs that can treat aggressive or hard-to-treat breast cancers 

WHAT:	Major investments in three unique cutting edge breast cancer research projects sponsored by the Canadian Cancer Society and the CQDM, a Quebec biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that will accelerate the discovery and development of safer and more effective biopharmaceutical drugs.
WHEN:	Saturday, June 1, 2019 From 10 am to 12:30 pm: a press conference will be held at 10:45 am Interviews can be conducted before and after the presentations.
WHERE:	CQDM office 740 Notre-Dame Street West, Suite 1400 Montreal
WHO:	Dr Morag Park, Alain Nepveu and Mark Basik: Three leading researchers from McGill University whose work aims to improve the diagnosis and treatment of breast cancer and to save the lives of thousands of women. These projects involve the participation of several Canadian biotech companies. Denis Lalonde, Executive Director of the Canadian Cancer Society - Quebec Diane Gosselin, President and CEO, CQDM Isabelle Racicot, spokesperson for the CIBC Run for the Cure, a CCS event that raises money for the breast cancer cause and that finances 100% the CCS's contribution to research funded through the CCS/CQDM partnership Mei-Lin Yee, survivor of highly advanced metastatic breast cancer

• The CCS is the largest national charitable funder of breast cancer research in Canada
• An estimated 1 in 8 women will be diagnosed with breast cancer in their lifetime. Breast cancer is the most commonly diagnosed cancer in women (26% of all new cancer cases). 
• Every year, an estimated 6,500 women in Quebec (over 26,000 across Canada) are diagnosed with breast cancer and approximately 300 die of the disease (5,000 across Canada).

SOURCE Canadian Cancer Society, Quebec Division

Jasmine Goupil, Public relation consultant for the Canadian Cancer Society, [email protected], 514 576-6611